The Prospective Segeberg Registry for Coronary Chronic Total Occlusions (CTO)
Recruiting
Observational Study
Coronary Chronic Total Occlusions
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- Segeberger Kliniken GmbH · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A Prospective Follow-up Assessment in Bad Segeberg with Patients undergoing Recanalization for Coronary Chronic Total Occlusion Lesion/s
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with coronary chronic total occlusions undergoing recanalization via percutaneous coronary interventions
Exclusion Criteria:
* None
Contacts